1. Home
  2. BOLT vs SKYQ Comparison

BOLT vs SKYQ Comparison

Compare BOLT & SKYQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • SKYQ
  • Stock Information
  • Founded
  • BOLT 2015
  • SKYQ 2019
  • Country
  • BOLT United States
  • SKYQ United States
  • Employees
  • BOLT N/A
  • SKYQ N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • SKYQ
  • Sector
  • BOLT Health Care
  • SKYQ
  • Exchange
  • BOLT Nasdaq
  • SKYQ NYSE
  • Market Cap
  • BOLT 22.6M
  • SKYQ 20.3M
  • IPO Year
  • BOLT 2021
  • SKYQ N/A
  • Fundamental
  • Price
  • BOLT $0.49
  • SKYQ $0.88
  • Analyst Decision
  • BOLT Hold
  • SKYQ
  • Analyst Count
  • BOLT 5
  • SKYQ 0
  • Target Price
  • BOLT $1.25
  • SKYQ N/A
  • AVG Volume (30 Days)
  • BOLT 114.3K
  • SKYQ 81.1K
  • Earning Date
  • BOLT 03-20-2025
  • SKYQ 03-04-2025
  • Dividend Yield
  • BOLT N/A
  • SKYQ N/A
  • EPS Growth
  • BOLT N/A
  • SKYQ N/A
  • EPS
  • BOLT N/A
  • SKYQ N/A
  • Revenue
  • BOLT $9,779,000.00
  • SKYQ $30,766,012.00
  • Revenue This Year
  • BOLT $9.87
  • SKYQ N/A
  • Revenue Next Year
  • BOLT N/A
  • SKYQ N/A
  • P/E Ratio
  • BOLT N/A
  • SKYQ N/A
  • Revenue Growth
  • BOLT 35.86
  • SKYQ N/A
  • 52 Week Low
  • BOLT $0.46
  • SKYQ $0.82
  • 52 Week High
  • BOLT $1.56
  • SKYQ $5.49
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 45.52
  • SKYQ N/A
  • Support Level
  • BOLT $0.48
  • SKYQ N/A
  • Resistance Level
  • BOLT $0.52
  • SKYQ N/A
  • Average True Range (ATR)
  • BOLT 0.03
  • SKYQ 0.00
  • MACD
  • BOLT 0.00
  • SKYQ 0.00
  • Stochastic Oscillator
  • BOLT 40.32
  • SKYQ 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

Share on Social Networks: